Home
overview
Despite recent economic uncertainties the cosmetics and personal care market has continued to thrive and the consumer market has been estimated to be worth US$180 billion and the industry has been predicted to enjoy strong growth over the next few years. However, consumers are proving increasingly difficult to please, demanding continual improvements in ingredients and beneficial effects. In this environment Cosmeceutical companies need to work harder than ever to be a success in today’s market.

This conference will endeavour to explore the research techniques that will eventually take over animal testing which is becoming less and less acceptable. Techniques such as phototoxicity, dermal absorption, skin corrosion testing and in vitro testing options will be evaluated. The Conference will aim to stimulate discussion on the latest advances in cosmetic Research & Development. This will include an assessment of the efficacy of novel ingredients and will look at how best to communicate these scientific advances to the consumer. The event will explore advances in modelling systems for preclinical development, how to speed up clinical trials and the latest developments in key markets such as anti-ageing and sun protection.



Gain an insight from the key industry speakers in the field:
  • David Carter, Manager, Medicines Borderline Section, Medicines & Healthcare Products Regulatory Agency (MHRA)
  • Dr Philippe Vanparys, Senior Research Fellow, Head, Genetic & In Vitro Toxicology, Johnson & Johnson
  • Dr Stuart Freeman, Director, Toxicology, GlaxoSmithKline
  • Frank Massino, Chairman & Chief Executive Officer, Senetek
  • Dirk Petersohn, Director, Research Skin/Hair Physiology, Henkel
  • Dr Jack Ferguson, Managing Director, Skinnovation
  • Dr Betsy Hughes-Formella, Managing Director, Bioskin

Programme highlights:
  • REGULATORY ISSUES IN COSMECEUTICALS: The latest on 'Cosmetic vs Drugs':, hear the update
  • INTERACTIVE PANEL DISCUSSION: Contributions from experienced practitioners 'Changing industry trends: the opportunities'
  • PRECLINICAL MODELS: Evaluate the recent developments in the use of reconstituted human and epithelial tissue models
  • THE LATEST DEVELOPMENTS IN PRODUCT DEVELOPMENT: Sun protection: hear the foundations for long term success
  • COMMERCIAL ISSUES IN THE COSMETIC INDUSTRY: Discover how to achieve brand success and take a look at the current and future marketing strategies

Conference programme

8:30 Registration & Coffee

9:00 Chairperson's Opening Remarks

Dr Jack Ferguson

Dr Jack Ferguson, Managing Director, Skinnovation

9:10 CLAIMS AND PRESENTATION TO ENSURE EARLY MARKETING OF YOUR PRODUCT IN EUROPE

Dr Peter Lassoff

Dr Peter Lassoff, Senior Director, Worldwide Regulatory Affairs, Parexel International Limited

  • Examples of products that can be sold as medical products or as cosmetics
  • Safety and efficacy requirements of drugs vs cosmetics
  • Cosmetic labelling, declaration of ingredients
  • How to choose between drug sales vs cosmetic sales
  • Early marketing of your cosmetic to gain funds for drug development
  • 9:50 EXPANDING YOUR COMPANY'S GROWTH POTENTIAL BY EXAMINING TRENDS IN THE COSMECEUTICAL MARKET

    Francine Porter

    Francine Porter, President, Osmotics Corporation

  • Consumer savvy and self-education – the increasing demand for independent clinical validation of new technologies
  • Nano technology (for increased permeation) a new ‘buzz word’ in cosmeceutical development
  • The cosmeceutical industry leaders – the companies that include a pharmaceutical division in their growth strategy
  • 10:30 Morning Coffee

    11:00 MEDICINAL PRODUCTS AND COSMETICS

    Mr David Carter

    Mr David Carter, Manager, Medicines Borderline Section, Medicines and Healthcare Products Regulatory Agency (MHRA)

  • Directive 2001/83/EC
  • The UK view
  • Working with the regulators
  • 11:40 CHANGING INDUSTRY TRENDS: THE OPPORTUNITIES

    .
    Mr David Carter

    Mr David Carter, Manager, Medicines Borderline Section, Medicines and Healthcare Products Regulatory Agency (MHRA)

    Dr Stuart Freeman

    Dr Stuart Freeman, Director, Toxicology, Glaxosmithkline Consumer Healthcare

    Mr Dirk Petersohn

    Mr Dirk Petersohn, Director of Research, Skin/Hair Pysiology, Henkel KGaA

    Mr Steven Porter

    Mr Steven Porter, CEO & Chairman, Osmotics Corporation

    Dr Jack Ferguson

    Dr Jack Ferguson, Managing Director, Skinnovation

    Dr Gareth Wakefield

    Dr Gareth Wakefield, Vice President, Research, Oxonica Limited

    Dr Betsy Hughes-Formella

    Dr Betsy Hughes-Formella, Managing Director, BioSkin

    12:20 Networking Lunch

    13:50 ASSURING THE SAFETY OF COSMECEUTICALS

    Dr Stuart Freeman

    Dr Stuart Freeman, Director, Toxicology, Glaxosmithkline Consumer Healthcare

  • Is testing necessary?
  • The changing regulatory scene in Europe
  • When to test, how to test
  • Alternatives to animals: in vitro models, computer models
  • Future prospects for safe non-animal tested products
  • 14:30 ALTERNATIVES TO ANIMAL TESTING IN THE PHARMACEUTICAL INDUSTRY

    Dr Philippe Vanparys

    Dr Philippe Vanparys, Senior Research Fellow & Head of Genetic & In …, Johnson & Johnson

  • The 3-R concept in pharmaceutical industry
  • Alternative tests for eye irritation: state of the art
  • Application of the BCOP and HET-CAM
  • Multi-center pre-validation of the human corneal epithelial model
  • In vitro embryotoxicity testing
  • Reduction of animal use by implementing new techniques
  • Case Study
  • 15:10 Afternoon Tea

    15:40 PRECLINICAL TOXICOLOGY AND PHARMACOLOGY TESTING

    Dr Bart de Wever

    Dr Bart de Wever, Business Development Director, Skinethic Laboratories

  • Skin and mucosal models
  • Acceptance of alternative methods for skin and eye irritation assessment
  • Future trends
  • 16:20 BIOACTIVES TARGETING INFLAMMATION

    Dr Guy Miller

    Dr Guy Miller, Chairman & CEO, GalileoPharma

  • Discovery strategies for identifying novel bioactives from plant derived sources
  • Rational formulation of synergistic mixtures using functional phenotypic screens
  • Discussed will be a reduction to practice of the discovery and formulation of plant-derived naturals as archetypical anti-inflammatory skin care bioactives.
  • 17:00 Chairperson’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairperson's Opening Remarks

    Mr Frank Massino

    Mr Frank Massino, Senior Executive / Chief Executive Officer, Senetek

    9:10 GENETICS AND COSMETICS

    Rosalynn Gill-Garrison

    Rosalynn Gill-Garrison, Cheif Technology Officer, Sciona

  • Genetic discoveries are yielding unprecedented opportunities in healthcare, nutrition and personal care
  • The consumer impact of genetic knowledge
  • Skin quality affected by ageing, environment, toxins, immune responses (diseases and allergies)
  • Many of these factors linked to specific genes and cellular pathways, individual variation in these pathways affects skin health and recovery in response to environmental events
  • Individual genetic variation can be identified and linked to specific advice on skincare and specific product formulations
  • Specific ingredients can be added to base product to cover ant-oxidant, micronutrient deficiencies, take account of DNA repair systems and growth factor status
  • Products can be designed to protect from potential damage as well as repair existing damage
  • Genetic personalisation provides the proprietary platform for advanced premium branded products
  • 9:50 MOLECULAR BASIS OF SKIN AGING

    Mr Dirk Petersohn

    Mr Dirk Petersohn, Director of Research, Skin/Hair Pysiology, Henkel KGaA

  • Identification of skin ageing marker genes
  • Development of a special DNA-chip for human skin
  • Description of bio-active ingredients using DNA-chip technology
  • 10:30 Morning Coffee

    11:00 THE FUTURE OF CYTOKININS IN SKIN CARE AND ANTI-AGING

  • What do we know about Cytokinins
  • An extensive portfolio of compounds
  • Their role in anti-ageing
  • Commercialisation of Cytokinins
  • Jan Barciszewski

    Jan Barciszewski, , Polish Academy Of Sciences

    Jerry McCullough

    Jerry McCullough, Director of Research, University Of California Irvine

    11:40 SUN PROTECTION

    Dr Jack Ferguson

    Dr Jack Ferguson, Managing Director, Skinnovation

  • The latest developments in sun product testing and labelling
  • Impact of new sun filters on quality of sun protection
  • Regulatory influence on global product strategy
  • The patent maze
  • New alternative concepts in sun protection
  • Future product positioning
  • 12:20 Networking Lunch

    14:00 SUNSCREENS AND UVA PROTECTION

    Dr Gareth Wakefield

    Dr Gareth Wakefield, Vice President, Research, Oxonica Limited

  • UVA exposure and solar damage
  • Quantifying UVA protection in respect to solar exposure time
  • Advantages and drawbacks of organic and inorganic UVA absorbing components
  • Modifying inorganic UVA absorbers: the influence of free radical load
  • Formulating with modified inorganic absorbers
  • Reducing and stabilising skin UVA exposure
  • 14:40 THE ROLE OF CLINICAL TRIALS IN THE DEVELOPMENT OF COSMETICS

    Dr Betsy Hughes-Formella

    Dr Betsy Hughes-Formella, Managing Director, BioSkin

  • Clinical trial endpoints and claim substantiation
  • Future trends in cosmeceutical clinical trials
  • Objectives, endpoints and design
  • Reducing time to market
  • 15:20 ACHIEVING BRAND SUCCESS

    Mr Steven Porter

    Mr Steven Porter, CEO & Chairman, Osmotics Corporation

  • Communicating key messages
  • Case studies
  • The combination of science and marketing is a must have strategy in the cosmeceutical arena
  • Current and future trends
  • Ultimate goals
  • 16:00 Chairperson’s Closing Remarks followed by Afternoon Tea and Close of Conference

    +

    The Hatton, at etc. venues

    51/53 Hatton Garden
    London EC1N 8HN
    United Kingdom

    The Hatton, at etc. venues

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.